Cargando…
2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant.
BACKGROUND: Despite the use of antimicrobial prophylaxis in liver transplant recipients (LTR), infection remains the most likely cause of death (18.94%) in the first year. There is limited data describing the characteristics, & infections of LTR while hospitalized in the first year post-transpla...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752692/ http://dx.doi.org/10.1093/ofid/ofac492.1733 |
_version_ | 1784850790377062400 |
---|---|
author | Alpizar-Rivas, Rodolfo M Palli, Rohith Croix, Michael Prasad, Paritosh Gupta, Purba Chuang, Sally |
author_facet | Alpizar-Rivas, Rodolfo M Palli, Rohith Croix, Michael Prasad, Paritosh Gupta, Purba Chuang, Sally |
author_sort | Alpizar-Rivas, Rodolfo M |
collection | PubMed |
description | BACKGROUND: Despite the use of antimicrobial prophylaxis in liver transplant recipients (LTR), infection remains the most likely cause of death (18.94%) in the first year. There is limited data describing the characteristics, & infections of LTR while hospitalized in the first year post-transplantation. We aimed to review the incidence and outcomes of infections in LTR in the first year post-transplant during hospitalization or re-hospitalization. [Figure: see text] Site of bacterial infection [Figure: see text] METHODS: We performed a single-center retrospective cohort study at The University of Rochester. Electronic medical records of 298 first time adult LTR between 03/5/2011 and 04/01/2020 were reviewed. Demographic and comorbidity data was obtained at time of transplant. Microbiologic data and outcomes were obtained during the first year post-transplant. We compared mortality between those with infection and those without using log-rank survival analysis. [Figure: see text] RESULTS: 160 (53.7%) patients suffered at least 1 infection while hospitalized in the first year post-transplant. There were 178 bacterial infections in 130 patients of which 115 were intra-abdominal (table 1). The most common organism was Enterococcus sp. (n=102), 65 were vancomycin resistant (VRE). The most common site of fungal infection was abdominal (n=13) and the most common organism was C. glabrata (n=9). The most common viral infection was CMV at 7-12 months although other viral infections occurred between 1-6 months (graph 2). In a univariate chi-square model, bacterial infection at any time was associated with all-cause mortality in the first year (CI 1.7-8.9 p-adj= 0.002). Fungal infection between 2-6 months was also associated with increased mortality (CI 2.7-12.2 p-adj= 0.0005). CONCLUSION: Bacterial infections are the most common type of infection in LTR and occur more frequently during the first 6 months. Bacterial infection at any point was independently associated with increased mortality in the first year post-transplant. The most common organism was Enterococcus with a high rate of VRE which should be taken into consideration for empiric coverage at our institution. Fungal infection between 2 to 6 months was associated with increased mortality. We observed that early bacterial and fungal infections are markers of poor prognosis. DISCLOSURES: All Authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-9752692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97526922022-12-16 2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. Alpizar-Rivas, Rodolfo M Palli, Rohith Croix, Michael Prasad, Paritosh Gupta, Purba Chuang, Sally Open Forum Infect Dis Abstracts BACKGROUND: Despite the use of antimicrobial prophylaxis in liver transplant recipients (LTR), infection remains the most likely cause of death (18.94%) in the first year. There is limited data describing the characteristics, & infections of LTR while hospitalized in the first year post-transplantation. We aimed to review the incidence and outcomes of infections in LTR in the first year post-transplant during hospitalization or re-hospitalization. [Figure: see text] Site of bacterial infection [Figure: see text] METHODS: We performed a single-center retrospective cohort study at The University of Rochester. Electronic medical records of 298 first time adult LTR between 03/5/2011 and 04/01/2020 were reviewed. Demographic and comorbidity data was obtained at time of transplant. Microbiologic data and outcomes were obtained during the first year post-transplant. We compared mortality between those with infection and those without using log-rank survival analysis. [Figure: see text] RESULTS: 160 (53.7%) patients suffered at least 1 infection while hospitalized in the first year post-transplant. There were 178 bacterial infections in 130 patients of which 115 were intra-abdominal (table 1). The most common organism was Enterococcus sp. (n=102), 65 were vancomycin resistant (VRE). The most common site of fungal infection was abdominal (n=13) and the most common organism was C. glabrata (n=9). The most common viral infection was CMV at 7-12 months although other viral infections occurred between 1-6 months (graph 2). In a univariate chi-square model, bacterial infection at any time was associated with all-cause mortality in the first year (CI 1.7-8.9 p-adj= 0.002). Fungal infection between 2-6 months was also associated with increased mortality (CI 2.7-12.2 p-adj= 0.0005). CONCLUSION: Bacterial infections are the most common type of infection in LTR and occur more frequently during the first 6 months. Bacterial infection at any point was independently associated with increased mortality in the first year post-transplant. The most common organism was Enterococcus with a high rate of VRE which should be taken into consideration for empiric coverage at our institution. Fungal infection between 2 to 6 months was associated with increased mortality. We observed that early bacterial and fungal infections are markers of poor prognosis. DISCLOSURES: All Authors: No reported disclosures. Oxford University Press 2022-12-15 /pmc/articles/PMC9752692/ http://dx.doi.org/10.1093/ofid/ofac492.1733 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstracts Alpizar-Rivas, Rodolfo M Palli, Rohith Croix, Michael Prasad, Paritosh Gupta, Purba Chuang, Sally 2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. |
title | 2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. |
title_full | 2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. |
title_fullStr | 2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. |
title_full_unstemmed | 2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. |
title_short | 2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. |
title_sort | 2112. incidence and outcomes of infections in liver transplant recipients during the first year post-transplant. |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752692/ http://dx.doi.org/10.1093/ofid/ofac492.1733 |
work_keys_str_mv | AT alpizarrivasrodolfom 2112incidenceandoutcomesofinfectionsinlivertransplantrecipientsduringthefirstyearposttransplant AT pallirohith 2112incidenceandoutcomesofinfectionsinlivertransplantrecipientsduringthefirstyearposttransplant AT croixmichael 2112incidenceandoutcomesofinfectionsinlivertransplantrecipientsduringthefirstyearposttransplant AT prasadparitosh 2112incidenceandoutcomesofinfectionsinlivertransplantrecipientsduringthefirstyearposttransplant AT guptapurba 2112incidenceandoutcomesofinfectionsinlivertransplantrecipientsduringthefirstyearposttransplant AT chuangsally 2112incidenceandoutcomesofinfectionsinlivertransplantrecipientsduringthefirstyearposttransplant |